Joel Wayment discusses the implications of the growing cell and gene therapy market on pharma supply chains. The rise in cell ...
Following his keynote address at LogiPharma Europe 2026, Nico Vandaele, professor of Operations Research & Operations ...
Joydeep Ganguly evaluates 4IR tools, data strategy, and why end-to-end thinking will define pharma supply chain ...
Pharmaceutical cold chain logistics is entering a phase where data quality and decision speed matter as much as physical ...
Gross-to-net concessions exceeding half of U.S. brand revenue make minor contracting and payment inefficiencies translate into hundreds of millions in leakage or compliance risk. Legacy revenue ...
Pharmaceutical supply chains operate with little room for error. From temperature-sensitive biologics to high-value specialty ...
discusses today's key risks in the pharma supply chain, and how to prevent disruptions.
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast in which we bring you the latest insights shaping patient access, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results